Skip to main content
Feedback
Professional Education
/
Transfusion
Learn.Share.Advance
Secondary Menu
Overview
Contact
Blog
EN
FR
EN
FR
Main menu
Transfusion
Organs and Tissues
Secondary Menu Mobile
Overview
Contact
Blog
Search
Leave this field blank
⚲
Transfusion Menu
Main navigation
COVID-19
COVID-19 FAQ: Information for health professionals on safety of transfused blood collected from COVID-19-vaccinated donors
COVID-19: FAQ for health professionals working with blood products
FAQ: SARS-CoV-2 antibodies in immunoglobulin products
Events
Past events
Courses
LearnTransfusion series
AFC-diploma program in transfusion medicine
Other courses and learning resources
BloodTechNet educational resources
KnowledgeInfusion
Transfusion Camp for nurse practitioners
General information
Module 1
Module 2
Module 3
Supplemental resources
Transfusion Camp in Rwanda 2023 - Train the Trainer Camp
Transfusion Camp
General information
Day 1
Day 2
Day 3
Day 4
Last year's content
Clinical guide
Chapter 1 - Vein to vein: A summary of the blood system in Canada
Chapter 2 - Blood components
Chapter 3 - Albumin
Chapter 4 - Immune globulin products
Chapter 5 - Concentrates for hemostatic disorders and hereditary angioedema
Chapter 6 - Donor selection, donor testing and pathogen reduction
Chapter 7 - Fractionated blood products and associated pathogen safety
Chapter 8 - Pre-transfusion testing
Chapter 9 - Blood administration
Chapter 10 - Transfusion reactions
Chapter 11 - Massive hemorrhage and emergency transfusion
Chapter 12 - Hemolytic disease of the fetus and newborn and perinatal immune thrombocytopenia
Chapter 13 - Neonatal and pediatric transfusion
Chapter 14 - Therapeutic apheresis
Chapter 15 - Irradiated, washed and CMV seronegative blood components
Chapter 16 - Preoperative autologous donation
Chapter 17 - Hemostatic disorders and hereditary angioedema
Chapter 18 - Platelet transfusion, alloimmunization and management of platelet refractoriness
Chapter 19 - Pathogen-reduced platelets
Best practices
Blood utilization best practices
Blood System Inventory Management Best Practices Guide
Platelet clinical best practices
Visual assessment guide
Uniform labelling
International Collaboration for Transfusion Medicine Guidelines (ICTMG)
Risk-based decision-making framework
Red cell antigen genotyping reports
Red cell antigen genotyping report: A quick glance
Interpreting the red cell antigen genotyping report (COMING SOON)
Serological best practices
ABO subgroups
Diego system: anti-Dia
Diego system: anti-Wra
Kell System: Anti-Kpa
Kell system: anti-Jsa
Lewis system: anti-Lewis
Lutheran system: anti-Lua
MNS system: anti-M
Rh System: Anti-V
Rh system: anti-Cw
Whole blood donors with antibodies
Testing and management of fetal and neonatal alloimmune thrombocytopenia
Publications
Molecular immunohematology at Canadian Blood Services: Red cell antigen genotyping
Paying it forward: Why we need YOU to give blood
Surveillance report
National plan for the management of shortages of labile blood components
Phenotype matching and storage age of blood for sickle cell patients: A review and recommendations for transfusion practice
Anaphylactic transfusion reactions and IgA deficiency
Transfusion-related acute lung injury (TRALI)
Emergency framework for rationing of blood for massively bleeding patients during a red phase blood shortage
Blood bag spiking procedure
Platelet product quality remains high after seven days of storage
A survey of Canadian MLTs’ views on continuing education in transfusion science
A Guide to Reporting Adverse Transfusion Reactions
Alternative methods of blood donor skin disinfection
Blood: the basics
Exploring the frontiers of IVIG-associated hemolysis
FAQ: Canadian Blood Services platelet bacterial screening
FAQ: Donor high titre isohemagglutinin (anti-A/anti-B) testing at Canadian Blood Services
FAQ: Information for health professionals on apheresis platelet psoralen-treated (APPT) and untreated apheresis platelet in PAS-E
FAQ: Information for health professionals on pathogen-reduced platelets
FAQ: Solvent detergent (S/D) treated plasma (Octaplasma)
Octaplasma: One-page clinical summary
FAQ: Whole blood, leukocytes reduced, at Canadian Blood Services
Impact of COVID-19 on blood donation in Canada
Striking the balance: protecting data privacy in research
Summary of adverse transfusion reactions 2017-2022
The importance of iron for whole blood donors: a Canadian perspective
Links
Canadian Society for Transfusion Medicine (CSTM)
National Advisory Committee on Blood and Blood Products
Provincial blood coordinating offices
Reference standards
Textbooks
Transfusionnews.com
Other links
Transfusion
Best practices
Share
